Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 14 results:
Author Title [ Type(Desc)] Year
Filters: Author is MacDonald, T. M.  [Clear All Filters]
Journal Article
S. V. Morant, Pettitt, D., MacDonald, T. M., Burke, T. A., and Goldstein, J. L., Application of a propensity score to adjust for channelling bias with NSAIDs, Pharmacoepidemiol Drug Saf, vol. 13, pp. 345-53, 2004.
J. George, Majeed, W., Mackenzie, I. S., MacDonald, T. M., and Wei, L., Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study, Bmj, vol. 347, p. f6954, 2013.
L. Wei, Mackenzie, I. S., MacDonald, T. M., and George, J., Cardiovascular risk associated with sodium-containing medicines, Expert Opin Drug Saf, vol. 13, pp. 1515-23, 2014.
A. Gilsenan, Fortuny, J., Cainzos-Achirica, M., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L., Harding, A., Kollhorst, B., Karlsson, P., Linner, L., MacDonald, T. M., Odsbu, I., Plana, E., Ruigomez, A., Schink, T., Ziemiecki, R., and Andrews, E. B., Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study, Drug Saf, 2019.
T. M. MacDonald, Morant, S. V., Goldstein, J. L., Burke, T. A., and Pettitt, D., Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs, Gut, vol. 52, pp. 1265-70, 2003.
T. M. MacDonald, Morant, S. V., and Mozaffari, E., Drug treatment discontinuation and achievement of target blood pressure and cholesterol in United Kingdom primary care, Curr Med Res Opin, vol. 23, pp. 2765-74, 2007.
M. Pauriah, Elder, D. H., Ogston, S., Noman, A. Y., Majeed, A., Wyatt, J. C., Choy, A. M., MacDonald, T. M., Struthers, A. D., and Lang, C. C., High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study, Heart, vol. 100, pp. 867-72, 2014.
I. S. Mackenzie, Morant, S. V., Bloomfield, G. A., MacDonald, T. M., and O'Riordan, J., Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database, J Neurol Neurosurg Psychiatry, vol. 85, pp. 76-84, 2014.
L. Wei, Lai, E. C., Kao-Yang, Y. H., Walker, B. R., MacDonald, T. M., and Andrew, R., Incidence of type 2 diabetes mellitus in men receiving steroid 5alpha-reductase inhibitors: population based cohort study, Bmj, vol. 365, p. l1204, 2019.
L. Wei, MacDonald, T. M., and Mackenzie, I. S., Pioglitazone and bladder cancer: a propensity score matched cohort study, Br J Clin Pharmacol, vol. 75, pp. 254-9, 2013.
D. Levin, Bell, S., Sund, R., Hartikainen, S. A., Tuomilehto, J., Pukkala, E., Keskimaki, I., Badrick, E., Renehan, A. G., Buchan, I. E., Bowker, S. L., Minhas-Sandhu, J. K., Zafari, Z., Marra, C., Johnson, J. A., Stricker, B. H., Uitterlinden, A. G., Hofman, A., Ruiter, R., de Keyser, C. E., MacDonald, T. M., Wild, S. H., McKeigue, P. M., and Colhoun, H. M., Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis, Diabetologia, vol. 58, pp. 493-504, 2015.
I. S. Mackenzie, MacDonald, T. M., Thompson, A., Morant, S., and Wei, L., Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study, Bmj, vol. 345, p. e4447, 2012.
I. S. Mackenzie, Morant, S. V., Wei, L., Thompson, A. M., and MacDonald, T. M., Spironolactone use and risk of incident cancers: a retrospective, matched cohort study, Br J Clin Pharmacol, vol. 83, pp. 653-663, 2017.
J. Fortuny, Gilsenan, A., Cainzos-Achirica, M., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L., Kollhorst, B., Karlsson, P., Linner, L., MacDonald, T. M., Plana, E., Ruigomez, A., Schink, T., Ziemiecki, R., and Andrews, E. B., Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350, Drug Saf, 2019.
[Page last reviewed 4 October 2019]